Research peptides · For laboratory and scientific research in vitro · Not medications · Not approved for consumption · Adults only (18+)
Hexarelin
In plain language
Hexarelin is one of the most potent peptides with additional researched cardioprotective effects via CD36 receptors.
For researchers
Hexarelin is a synthetic hexapeptide (growth hormone-releasing peptide) from the ghrelin mimetic family. It binds the GHS-R1a receptor in pituitary and hypothalamus, triggering potent growth hormone release — one of the strongest in the category, first described by Deghenghi and Ghigo's group (Turin, 1990s). Beyond -secretagogue activity, published literature (Locatelli, Torsello, Tivesten) documents direct cardioprotective effects independent of the / axis. Research on cardiovascular ischemia and left ventricular function shows potential beyond purely metabolic applications. Hexarelin also binds CD36 receptors in cardiomyocytes, explaining its unique tissue selectivity. A practical aspect is pronounced desensitization with prolonged use — receptors downregulate faster than with Ipamorelin or -2, making cyclic protocols mandatory for research. Half-life ~70 minutes. Storage: -20°C lyophilized, stable in reconstituted solution up to 21 days at 2-8°C.
Scientific literature
Other peptides
Information about Hexarelin is based on published scientific research and is intended for research purposes. Not medical advice.
Products related to this peptide are for in vitro laboratory research only. Not approved for human consumption.